But isn’t the case that faster you fail you get to the goal post better? Terminally ill trial vs non terminally ill can be differentiated somehow while measurin

But isn’t the case that faster you fail you get to the goal post better? Terminally ill trial vs non terminally ill can be differentiated somehow while measuring efficacy and other post trial parameters ?